Return of Results in Genomic Research Using Large-Scale or Whole Genome Sequencing: Toward a New Normal
- PMID: 36913714
- PMCID: PMC10497726
- DOI: 10.1146/annurev-genom-101122-103209
Return of Results in Genomic Research Using Large-Scale or Whole Genome Sequencing: Toward a New Normal
Abstract
Genome sequencing is increasingly used in research and integrated into clinical care. In the research domain, large-scale analyses, including whole genome sequencing with variant interpretation and curation, virtually guarantee identification of variants that are pathogenic or likely pathogenic and actionable. Multiple guidelines recommend that findings associated with actionable conditions be offered to research participants in order to demonstrate respect for autonomy, reciprocity, and participant interests in health and privacy. Some recommendations go further and support offering a wider range of findings, including those that are not immediately actionable. In addition, entities covered by the US Health Insurance Portability and Accountability Act (HIPAA) may be required to provide a participant's raw genomic data on request. Despite these widely endorsed guidelines and requirements, the implementation of return of genomic results and data by researchers remains uneven. This article analyzes the ethical and legal foundations for researcher duties to offer adult participants their interpreted results and raw data as the new normal in genomic research.
Keywords: genomics; incidental findings; research ethics; return of results; secondary findings; whole genome sequencing.
Figures
Similar articles
-
Ethical and Legal Implications of Remote Monitoring of Medical Devices.Milbank Q. 2020 Dec;98(4):1257-1289. doi: 10.1111/1468-0009.12481. Epub 2020 Oct 20. Milbank Q. 2020. PMID: 33078879 Free PMC article.
-
Responsible conduct of radiology research. Part V. The Health Insurance Portability and Accountability Act and research.Radiology. 2005 Dec;237(3):757-64. doi: 10.1148/radiol.2373041148. Radiology. 2005. PMID: 16304095
-
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.Genet Med. 2013 Nov;15(11):860-7. doi: 10.1038/gim.2013.133. Epub 2013 Oct 24. Genet Med. 2013. PMID: 24195999 Free PMC article. Review.
-
A novel 'social contract' - An attempt to harmonize a sponsor's exploratory research with a clinical study participant's data rights.Contemp Clin Trials. 2022 Aug;119:106819. doi: 10.1016/j.cct.2022.106819. Epub 2022 Jun 9. Contemp Clin Trials. 2022. PMID: 35691489
-
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) privacy rule: implications for clinical research.Annu Rev Med. 2006;57:575-90. doi: 10.1146/annurev.med.57.121304.131257. Annu Rev Med. 2006. PMID: 16409167 Review.
Cited by
-
Interrogating the Value of Return of Results for Diverse Populations: Perspectives from Precision Medicine Researchers.AJOB Empir Bioeth. 2024 Apr-Jun;15(2):108-119. doi: 10.1080/23294515.2023.2279965. Epub 2023 Nov 14. AJOB Empir Bioeth. 2024. PMID: 37962912
-
Patient safety and healthcare quality of U.S. laboratory developed tests (LDTs) in the AI/ML era of precision medicine.Front Mol Biosci. 2024 Aug 5;11:1407513. doi: 10.3389/fmolb.2024.1407513. eCollection 2024. Front Mol Biosci. 2024. PMID: 39165642 Free PMC article.
-
Studying the impact of translational genomic research: Lessons from eMERGE.Am J Hum Genet. 2023 Jul 6;110(7):1021-1033. doi: 10.1016/j.ajhg.2023.05.011. Epub 2023 Jun 20. Am J Hum Genet. 2023. PMID: 37343562 Free PMC article. Review.
-
All of Us participant perspectives on the return of value in research.Genet Med. 2024 Aug;26(8):101163. doi: 10.1016/j.gim.2024.101163. Epub 2024 May 9. Genet Med. 2024. PMID: 38738530 Free PMC article.
References
-
- ACMG Board Dir. 2012. Points to consider in the clinical application of genomic sequencing. Genet. Med 14:759–61 - PubMed
-
- ACMG Board Dir. 2015. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet. Med 17:68–69 - PubMed
-
- ACMG Board Dir. 2015. Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics. Genet. Med 17:505–7 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources